Inventor · disambiguated record
Zenon D. Konteatis
Also filed as: KONTEATIS ZENON · KONTEATIS ZENON D
22 granted patents·13 pending applications·121 citations·filing 1991–2024
94Inventor score
Files withAGIOS PHARMACEUTICALS INC15SERVIER PHARMACEUTICALS LLC4MERCK & CO INC3LES LABORATOIRES SERVIER SAS2SERVIER LAB2
Top patents by PatentIndex Score
35 records- 0197US9579324B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2014·Granted Feb 28, 2017·22 cites·6 claims
- 0296US10800782B2Inhibitors of cellular metabolic processesAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Oct 13, 2020·8 cites·42 claims
- 0395US10172864B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Jan 8, 2019·8 cites·21 claims
- 0494US11325914B1Inhibitors of cellular metabolic processesAGIOS PHARMACEUTICALS INC·Filed 2020·Granted May 10, 2022·2 cites·25 claims
- 0593US10329298B2Inhibitors of cellular metabolic processesAGIOS PHARMACEUTICALS INC·Filed 2017·Granted Jun 25, 2019·11 cites·32 claims
- 0690US10028961B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Jul 24, 2018·4 cites·9 claims
- 0788US11919915B2Compounds and methods useful for stabilizing phenylalanine hydroxylase mutationsAGIOS PHARMACEUTICALS INC·Filed 2023·Granted Mar 5, 2024·1 cites·30 claims
- 0887US11844758B2Therapeutically active compounds and their methods of useSERVIER PHARMACEUTICALS LLC·Filed 2021·Granted Dec 19, 2023·1 cites·20 claims
- 0980US7196106B2Cyanothiophene derivatives, compositions containing such compounds and methods of useMERCK & CO INC·Filed 2003·Granted Mar 27, 2007·12 cites·9 claims
- 1079US11524960B2Heterobicyclic inhibitors of MAT2A and methods of use for treating cancerAGIOS PHARMACEUTICALS INC·Filed 2019·Granted Dec 13, 2022·2 cites·44 claims
- 1177US12433895B2Therapeutically active compounds and their methods of useSERVIER PHARMACEUTICALS LLC·Filed 2023·Granted Oct 7, 2025·0 cites·20 claims
- 1277USRE49934EInhibitors of cellular metabolic processesSERVIER PHARMACEUTICALS LLC·Filed 2022·Granted Apr 23, 2024·0 cites·45 claims
- 1377US10376510B22,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancerAGIOS PHARMACEUTICALS INC·Filed 2014·Granted Aug 13, 2019·3 cites·15 claims
- 1474US2025262201A1Compounds and methods useful for stabilizing phenylalanine hydroxylase mutationsAGIOS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1572US2023365592A1Compounds and methods useful for stabilizing phenylalanine hydroxylase mutationsAGIOS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1672US2025214988A1Heterobicyclic inhibitors of mat2a and methods of use for treating cancerSERVIER LAB·Filed 2024·Application pending·0 cites
- 1770US7687495B2Substituted piperidinesSPEEDEL EXPERIMENTA AG·Filed 2008·Granted Mar 30, 2010·1 cites·12 claims
- 1869US2025171438A1Compounds and methods useful for stabilizing phenylalanine hydroxylase mutationsAGIOS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1967US10946023B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Mar 16, 2021·0 cites·35 claims
- 2065US2025171437A1(4-benzo[d]oxazol-2-yl)-6,7-dihydro-1h-imidazo[4,5-c]pyridine-5(4h)-yl)methanone derivatives as mutant pah stabilizers for the treatment of phenylketonuriaAGIOS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2164US5614370AAssay to identify human C5a antagonists and agonistsMERCK & CO INC·Filed 1994·Granted Mar 25, 1997·25 cites·7 claims
- 2260US2025320201A1Compounds and methods useful for stabilizing phenylalanine hydroxylase mutationsAGIOS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2357US5494898APeptide skeletal muscle relaxantsOHMEDA PHARMA PROD·Filed 1994·Granted Feb 27, 1996·15 cites·11 claims
- 2454US12077534B2Aza-heterobicyclic inhibitors of MAT2A and methods of use for treating cancerLES LABORATOIRES SERVIER SAS·Filed 2019·Granted Sep 3, 2024·0 cites·35 claims
- 2552US2022169654A1New Organic CompoundsSERVIER PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 2649US2004097557A1Cyanothiophene derivatives, compositions containing such compounds and methods of useFiled 2003·Application pending·0 cites
- 2749US2010029628A12,4,5-Substituted Piperidines as Renin InhibitorsHEROLD PETER·Filed 2006·Application pending·0 cites
- 2848US2022251081A1Heterobicyclic inhibitors of mat2a and methods of use for treating cancerSERVIER LAB·Filed 2020·Application pending·0 cites
- 2945US2022098203A1Aza-heterobicyclic inhibitors of mat2a and methods of use for treating cancerLES LABORATOIRES SERVIER SAS·Filed 2019·Application pending·0 cites
- 3043US5190924APeptide amides and amide dimers useful as muscle relaxantsBOC HEALTH CARE·Filed 1991·Granted Mar 2, 1993·6 cites·13 claims
- 3140US7273876B2Substituted bicylic thiophene derivatives, compositions containing such compounds and methods of useMERCK & CO INC·Filed 2003·Granted Sep 25, 2007·0 cites·10 claims
- 3240US2006035958A1Method of treating diabetes and related conditionsDUFFY JOSEPH·Filed 2003·Application pending·0 cites
- 3338US7741479B2Urea inhibitors of MAP kinasesLOCUS PHARMACEUTICALS INC·Filed 2005·Granted Jun 22, 2010·0 cites·19 claims
- 3438US2002094989A1Pyrrolidine modulators of CCR5 chemokine receptor activityFiled 2001·Application pending·0 cites
- 3526US8765754B2Pyrrolotriazine compoundsKONTEATIS ZENON·Filed 2010·Granted Jul 1, 2014·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →